Thomas Goronflot
Overview
Explore the profile of Thomas Goronflot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
260
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vitek L, Goronflot T, Dutriaux C, Deleuze A, Le Corre Y, Duval-Modeste A, et al.
Acta Derm Venereol
. 2024 Dec;
104:adv41297.
PMID: 39670438
Metastatic uveal melanoma is a rare disease with a poor prognosis. Usual treatments have not proven effective. Tebentafusp, a bispecific protein targeting melanoma cells and T lymphocytes, is the first...
2.
Golinvaux E, Goronflot T, Cadiet J, Senage T, Rozec B, Boissier E, et al.
J Cardiothorac Vasc Anesth
. 2024 Oct;
38(12):3086-3093.
PMID: 39426856
Objectives: Hemolysis is a contributor to CS-AKI. Biochemistry analyzers provide a hemolysis index to quantify in vitro hemolysis, a condition that can, for example, affect the accuracy of potassium concentration...
3.
Broquet A, Gourain V, Goronflot T, Le Mabecque V, Sinha D, Ashayeripanah M, et al.
Nat Immunol
. 2024 Oct;
25(11):2167.
PMID: 39375552
No abstract available.
4.
Martin F, Goronflot T, Moyer J, Huet O, Asehnoune K, Cinotti R, et al.
Neurocrit Care
. 2024 Aug;
PMID: 39138720
Background: The prognostication of long-term functional outcomes remains challenging in patients with traumatic brain injury (TBI). Our aim was to demonstrate that intensive care unit (ICU) variables are not efficient...
5.
Graveleau P, Frampas E, Perret C, Volpi S, Blanc F, Goronflot T, et al.
Res Diagn Interv Imaging
. 2024 Jul;
10:100047.
PMID: 39077729
Purpose: To assess the efficacy of the gelatin torpedoes embolization technique after lung neoplastic lesions percutaneous radiofrequency ablation (PRFA) to reduce chest tube placement rate and hospital length of stay,...
6.
Pons-Tostivint E, Ezzedine R, Goronflot T, Crequit P, Chatellier T, Raimbourg J, et al.
Lung Cancer
. 2024 Jul;
194:107887.
PMID: 38991282
Introduction: Chemotherapy combined with immunotherapy (CT-IO) is the standard treatment for patients with Extensive-Stage Small Cell Lung Cancer (ES-SCLC). This study evaluates the effectiveness of second-line (2L) following CT-IO. Patients...
7.
Karakachoff M, Goronflot T, Coudol S, Toublant D, Bazoge A, Constant Dit Beaufils P, et al.
JMIR Med Inform
. 2024 Jun;
12:e50194.
PMID: 38915177
Background: Biomedical data warehouses (BDWs) have become an essential tool to facilitate the reuse of health data for both research and decisional applications. Beyond technical issues, the implementation of BDWs...
8.
Broquet A, Gourain V, Goronflot T, Le Mabecque V, Sinha D, Ashayeripanah M, et al.
Nat Immunol
. 2024 Apr;
25(5):802-819.
PMID: 38684922
Sepsis induces immune alterations, which last for months after the resolution of illness. The effect of this immunological reprogramming on the risk of developing cancer is unclear. Here we use...
9.
Tissot A, Durand E, Goronflot T, Coiffard B, Renaud-Picard B, Roux A, et al.
Respir Res
. 2024 Feb;
25(1):88.
PMID: 38336710
Background: Long-term outcomes of lung transplantation (LTx) remain hampered by chronic lung allograft dysfunction (CLAD). Matrix metalloproteinase 9 (MMP-9) is a secretory endopeptidase identified as a key mediator in fibrosis...
10.
Wargny M, Goronflot T, Rimbert A, Boursier J, Kab S, Henny J, et al.
J Hepatol
. 2024 Feb;
80(6):846-857.
PMID: 38331324
Background & Aims: Beyond cardiovascular disease protection, the health consequences of very low concentrations of low-density lipoprotein-cholesterol (LDL-C) remain a matter of debate. In primary hypobetalipoproteinemia (HBL), liver steatosis and...